CRISPR-mediated engineering of bovine satellite cells for Alpha-Gal Syndrome-compatible cultivated meat
Preprint
Abstract
Alpha-gal Syndrome (AGS) is a potentially life-threatening allergy caused by an IgE-mediated immune response to galactose-α-1,3-galactose (alpha-gal), a carbohydrate epitope present in most mammalian meats. Currently, strict avoidance of mammalian meat remains the primary management strategy for affected individuals, and alpha-gal-free beef is not commercially available. Here, we leverage cultivated meat as a biotechnology plat-form to address this unmet clinical need by engineering alpha-gal–free bovine muscle cells. Using CRISPR/Cas9 genome editing, we disrupted GGTA1, the gene encoding α1,3-galactosyltransferase, in immortalized bovine satellite cells (iBSCs). High-efficiency editing produced clonal GGTA1 knockout iBSCs harboring a homozygous frameshift mutation. Flow cytometry and immunofluorescence confirmed loss of the alpha-gal epitope, while bulk RNA-seq indicated minimal disruption of global gene expression and preserved myogenic differentiation capacity. Importantly, lysates from GGTA1 knockout iBSCs elicited substantially reduced basophil activation in assays using plasma from a patient with AGS, indicating reduced basophil activation consistent with reduced allergenic potential. Together, these findings establish a proof of concept for engineering AGS-compatible cultivated meat and demonstrate the potential of cultivated meat technologies to address human health challenges. HIGHLIGHTS: ∘ CRISPR/Cas9-mediated disruption of GGTA1 eliminated alpha-gal from bovine satellite cells ∘ GGTA1 knockout cells retained myogenic identity and differentiation capacity ∘ GGTA1 knockout reduced basophil activation in an alpha-gal syndrome immune assay ∘ Genome-edited bovine cells provide a proof of concept for AGS-compatible cultivated meatKeywords
Funding Information
- NIH (R35GM128645)
- NIH (R01AI135049)
- Matthew 6 Fund
This publication has 28 references indexed in Scilit:
- Altered Levels of Known Allergens in Cultured Primary Bovine Myoblasts for Cultivated MeatJournal of Agricultural and Food Chemistry, 2026
- Implications of a fatal anaphylactic reaction occurring 4 hours after eating beef in a young man with IgE antibodies to galactose-α-1,3-galactoseThe Journal of Allergy and Clinical Immunology: In Practice, 2025
- Identification of Alpha-Gal glycolipids in saliva of Lone-Star Tick (Amblyomma americanum)Ticks and Tick-borne Diseases, 2024
- Genetically engineered sheep: A new paradigm for future preclinical testing of biological heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 2023
- Diagnostic testing for galactose-alpha-1,3-galactose, United States, 2010 to 2018Annals of Allergy, Asthma & Immunology, 2021
- The changing face of anaphylaxis in adults and adolescentsAnnals of Allergy, Asthma & Immunology, 2018
- Bringing cultured meat to market: Technical, socio-political, and regulatory challenges in cellular agricultureTrends in Food Science & Technology, 2018
- Cultured meat from stem cells: Challenges and prospectsMeat Science, 2012
- Delayed Anaphylaxis to Red Meat in Patients with IgE Specific for Galactose alpha-1,3-Galactose (alpha-gal)Current Allergy and Asthma Reports, 2012
- Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-α-1,3-galactoseJournal of Allergy and Clinical Immunology, 2009